Clover Health Investments Corp. [NASDAQ: CLOV] jumped around 0.03 points on Friday, while shares priced at $0.98 at the close of the session, up 2.60%. The company report on May 9, 2023 at 4:34 PM that Clover Health Reports First Quarter 2023 Financial Results.
Insurance revenue grew by 14% over Q1’22.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Insurance and Non-Insurance MCR improved to 86.6% and 96.1%, respectively.
Clover Health Investments Corp. stock is now 4.90% up from its year-to-date (YTD) trading value. CLOV Stock saw the intraday high of $0.9873 and lowest of $0.9349 per share. The company’s 52-week high price is 3.55, which means current price is +37.75% above from all time high which was touched on 02/02/23.
Compared to the average trading volume of 6.73M shares, CLOV reached a trading volume of 10797807 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Clover Health Investments Corp. [CLOV]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLOV shares is $1.55 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLOV stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cowen have made an estimate for Clover Health Investments Corp. shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on February 02, 2022. While these analysts kept the previous recommendation, Canaccord Genuity raised their target price to Buy. The new note on the price target was released on February 02, 2022, representing the official price target for Clover Health Investments Corp. stock. Previously, the target price had yet another raise to $3, while SVB Leerink analysts kept a Mkt Perform rating on CLOV stock. On January 10, 2022, analysts decreased their price target for CLOV shares from 9 to 3.50.
The Average True Range (ATR) for Clover Health Investments Corp. is set at 0.06, with the Price to Sales ratio for CLOV stock in the period of the last 12 months amounting to 0.15. The Price to Book ratio for the last quarter was 1.46, with the Price to Cash per share for the same quarter was set at 1.06.
How has CLOV stock performed recently?
Clover Health Investments Corp. [CLOV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 20.37. With this latest performance, CLOV shares gained by 17.24% in over the last four-week period, additionally sinking by -20.73% over the last 6 months – not to mention a drop of -54.23% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLOV stock in for the last two-week period is set at 67.01, with the RSI for the last a single of trading hit 75.84, and the three-weeks RSI is set at 59.96 for Clover Health Investments Corp. [CLOV]. The present Moving Average for the last 50 days of trading for this stock 0.8606, while it was recorded at 0.9299 for the last single week of trading, and 1.4875 for the last 200 days.
Clover Health Investments Corp. [CLOV]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Clover Health Investments Corp. [CLOV] shares currently have an operating margin of -10.35. Clover Health Investments Corp.’s Net Margin is presently recorded at -9.72.
Return on Total Capital for CLOV is now -80.57, given the latest momentum, and Return on Invested Capital for the company is -74.31. Return on Equity for this stock declined to -76.74, with Return on Assets sitting at -38.52. When it comes to the capital structure of this company, Clover Health Investments Corp. [CLOV] has a Total Debt to Total Equity ratio set at 1.69. Additionally, CLOV Total Debt to Total Capital is recorded at 1.66, with Total Debt to Total Assets ending up at 0.72. Long-Term Debt to Equity for the company is recorded at 1.16, with the Long-Term Debt to Total Capital now at 1.14.
Reflecting on the efficiency of the workforce at the company, Clover Health Investments Corp. [CLOV] managed to generate an average of -$516,530 per employee.Clover Health Investments Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.10 and a Current Ratio set at 1.10.
Earnings analysis for Clover Health Investments Corp. [CLOV]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLOV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Clover Health Investments Corp. go to 19.10%.
Insider trade positions for Clover Health Investments Corp. [CLOV]
There are presently around $122 million, or 32.50% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: VANGUARD GROUP INC with ownership of 32,158,748, which is approximately 4.04% of the company’s market cap and around 3.10% of the total institutional ownership; BLACKROCK INC., holding 26,603,106 shares of the stock with an approximate value of $25.94 million in CLOV stocks shares; and STATE STREET CORP, currently with $8.62 million in CLOV stock with ownership of nearly 8.437% of the company’s market capitalization.
69 institutional holders increased their position in Clover Health Investments Corp. [NASDAQ:CLOV] by around 13,805,153 shares. Additionally, 69 investors decreased positions by around 11,857,803 shares, while 55 investors held positions by with 99,715,132 shares. The mentioned changes placed institutional holdings at 125,378,088 shares, according to the latest SEC report filing. CLOV stock had 21 new institutional investments in for a total of 1,181,911 shares, while 27 institutional investors sold positions of 5,851,936 shares during the same period.